The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
What Do Mounjaro Reviews Tell Us About This Weight Loss Injection?
Mounjaro (tirzepatide) is a prescription-only weight loss injection that has generated significant interest in the UK. While individual experiences vary widely, real-world feedback and clinical trial data can help you understand what to expect. This guide covers what UK users report, clinical evidence, side effects, and how Mounjaro compares to other weight loss options. Always consult your GP before considering any prescription medication for weight management.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What Do Clinical Trials and User Reviews Reveal About Mounjaro?
Mounjaro is a dual GIP and GLP-1 receptor agonist — meaning it activates two natural hormone pathways to regulate appetite and support weight management. The SURMOUNT-1 clinical trial, which forms the basis of Mounjaro's UK approval, showed participants lost an average of 15–20.9% of their body weight over 72 weeks, depending on the dose used.
Real-world reviews from UK users highlight both positive outcomes and challenges:
- Positive feedback: Reduced appetite and food cravings, feeling fuller on smaller portions, improved energy levels after initial adjustment, modest to significant weight loss when combined with diet and exercise
- Challenges reported: Nausea during the first 1–2 weeks (often improves), constipation or diarrhoea, injection site bruising, hair loss in some users, cost (if accessing privately)
Individual results vary significantly — some people lose 5–10% body weight, others 20%+ over several months. Results depend on starting weight, adherence to dose escalation, lifestyle factors, and individual metabolism.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
How Do People Access Mounjaro in the UK, and What Are the Real Costs?
In the UK, Mounjaro is available through two routes: NHS specialist weight management services and private prescribing via GPhC-registered pharmacies.
NHS access: Requires referral from your GP to a tier 3 or tier 4 weight management service. Availability and waiting times vary significantly by region. Some areas have waiting lists of 6–12 months.
Private access: Available through online clinics following a brief assessment by a UK-licensed prescriber. Private costs typically range from £129–£320 per month, depending on dose. A KwikPen (4-week supply) costs approximately £130–£160 at current private rates.
Use our GLP-1 weight loss calculator above to estimate potential weight loss at different doses, and our BMI calculator to check your starting point. Track your progress over time with our free progress tracker tool.
Mounjaro reviews emphasise that results are most impressive when combined with a reduced-calorie diet and regular physical activity. Weight loss plateaus are common after 3–6 months, and some users report the need to increase their dose or switch to a different medication. Cost, availability, and individual tolerability remain the main barriers to access reported by UK users considering Mounjaro.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
What dose do most UK users start on, and how quickly do they see results?
Most UK users begin on 2.5 mg, increased gradually every 4 weeks up to a maximum of 15 mg. Weight loss typically becomes noticeable within 4–8 weeks at maintenance doses. Average loss at 10 mg is approximately 19.5% body weight over 72 weeks, though individual results vary significantly depending on lifestyle factors and starting weight.
Are the side effects reported in Mounjaro reviews permanent?
Most side effects are temporary. Nausea often improves within 1–2 weeks. Constipation and diarrhoea tend to settle as the body adjusts. Injection site reactions are usually mild. Serious side effects are rare but require immediate medical attention if severe abdominal pain or allergic reactions occur. Always inform your prescriber of persistent side effects.
How does Mounjaro compare to Wegovy based on real-world reviews?
Both are prescription-only UK-licensed weight loss injections. Mounjaro uses dual GIP+GLP-1 mechanism and showed average weight loss of 15–20.9% in trials. Wegovy (semaglutide) is a GLP-1 receptor agonist with average weight loss around 14.9%. Clinical trial results show Mounjaro slightly higher on average, but individual responses vary. Both require prescription and clinical assessment.
Can I get Mounjaro on the NHS, and what's the waiting time?
Mounjaro is approved by NICE for NHS use, but only through tier 3 specialist weight management services. You must be referred by your GP. Waiting times vary dramatically by region — some areas have waits of 6–12 months. Private online prescribing offers faster access but involves cost. Contact your local ICB to check current NHS availability in your area.
What do UK reviews say about Mounjaro and weight rebound after stopping?
Users report that weight tends to gradually return if Mounjaro is stopped without sustained lifestyle changes. Clinical data suggests weight loss is maintained only when diet and exercise habits remain improved. Reviews emphasise that Mounjaro is not a permanent solution — it's a support tool that works best alongside lasting behaviour change and reduced-calorie eating.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.